Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00576095 · ClinicalTrials.gov registry record

Clinical and Biological Characteristics of Psychotic Depression

A clinical trial of Depression and Depressive Disorder, Major, sponsored by Stanford University.

Completed
Registry status
73
Enrollment target
1
Study location

NCT00576095 is a study of Depression and Depressive Disorder, Major that has completed, run by Stanford University. The registered enrollment target is 73 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00576095, a study of Depression and Depressive Disorder, Major, has completed, sponsored by Stanford University.

COMPLETED
Registry status
73 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this study is to investigate the relationships among findings in structural and functional neuroimaging, cognitive testing and HPA (hypothalamic-pituitary-adrenal) axis dysregulation in psychotic depression.

Study Locations (1)

California

  • Stanford University School of Medicine - Stanford

Trial Details

FieldValue
Enrollment Target 73 participants
Start Date 2005-08
Est. Completion 2012-06

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT00576095

The ClinicalTrials.gov registry entry for NCT00576095 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (91% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 0 interventions.

NCT00576095 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00576095 about?

NCT00576095 is a clinical study titled "Clinical and Biological Characteristics of Psychotic Depression". The primary objective of this study is to investigate the relationships among findings in structural and functional neuroimaging, cognitive testing and HPA (hypothalamic-pituitary-adrenal) axis dysregulation in psychotic depression.

What is the current status of trial NCT00576095?

This trial is currently completed. The enrollment target is 73 participants. The study started on 2005-08. Estimated completion is 2012-06.

What conditions does trial NCT00576095 study?

This clinical trial studies the following conditions: Depression, Depressive Disorder, Major, Psychotic Disorders.

Who is sponsoring clinical trial NCT00576095?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00576095 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.